Among these T2D patients, 1956 received insulin (either alone or in combination with sulfonylurea, metformin, or acarbose) and 1926 patients received sulfonylurea (either alone or in combination with metformin or acarbose). The gene discussed is INS; the disease is type 2 diabetes mellitus.